ZA200206153B - Proteins comprising conserved regions of Neisseria meningitidis surface antigent NhhA. - Google Patents

Proteins comprising conserved regions of Neisseria meningitidis surface antigent NhhA.

Info

Publication number
ZA200206153B
ZA200206153B ZA200206153A ZA200206153A ZA200206153B ZA 200206153 B ZA200206153 B ZA 200206153B ZA 200206153 A ZA200206153 A ZA 200206153A ZA 200206153 A ZA200206153 A ZA 200206153A ZA 200206153 B ZA200206153 B ZA 200206153B
Authority
ZA
South Africa
Prior art keywords
antigent
nhha
proteins
neisseria meningitidis
conserved regions
Prior art date
Application number
ZA200206153A
Other languages
English (en)
Inventor
Ian Richard Anselm Peak
Michael Paul Jennings
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of ZA200206153B publication Critical patent/ZA200206153B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200206153A 2000-01-25 2002-08-01 Proteins comprising conserved regions of Neisseria meningitidis surface antigent NhhA. ZA200206153B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17791700P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
ZA200206153B true ZA200206153B (en) 2003-11-03

Family

ID=22650445

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206153A ZA200206153B (en) 2000-01-25 2002-08-01 Proteins comprising conserved regions of Neisseria meningitidis surface antigent NhhA.

Country Status (18)

Country Link
US (4) US7947291B2 (cs)
EP (2) EP1252182B1 (cs)
JP (3) JP2003523208A (cs)
KR (1) KR100698561B1 (cs)
CN (2) CN102417537A (cs)
AU (1) AU2818101A (cs)
BR (1) BR0107857A (cs)
CA (1) CA2398139A1 (cs)
CZ (1) CZ304379B6 (cs)
ES (1) ES2389719T3 (cs)
HU (1) HUP0300696A3 (cs)
IL (2) IL150822A0 (cs)
MX (1) MXPA02007184A (cs)
NO (1) NO332229B1 (cs)
NZ (1) NZ520445A (cs)
PL (1) PL216780B1 (cs)
WO (1) WO2001055182A1 (cs)
ZA (1) ZA200206153B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
AU761780B2 (en) 1998-05-01 2003-06-12 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
DK1228217T3 (da) * 1999-04-30 2013-02-25 Novartis Vaccines & Diagnostic Konserverede neisseria-antigener
EP2270174A1 (en) * 1999-05-19 2011-01-05 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
CZ304379B6 (cs) * 2000-01-25 2014-04-09 The University Of Queensland Proteiny obsahující konzervované oblasti povrchového antigenu NhhA z Neisseria meningitidis
CN101906413A (zh) 2000-02-28 2010-12-08 启龙有限公司 奈瑟球菌蛋白质的异源表达
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
EP1524993B1 (en) * 2002-08-02 2013-03-06 GlaxoSmithKline Biologicals s.a. Neisserial vaccine compositions comprising a combination of antigens
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
ATE492288T1 (de) 2002-10-11 2011-01-15 Novartis Vaccines & Diagnostic Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
WO2007042326A2 (en) * 2005-10-14 2007-04-19 Intercell Ag Neisseria meningitidis antigens
EP2032160B2 (en) 2006-06-12 2013-04-03 GlaxoSmithKline Biologicals S.A. Vaccine
US20100189737A1 (en) 2008-12-17 2010-07-29 Arico Beatrice Meningococcal vaccines including hemoglobin receptor
CN102427826B (zh) 2009-03-24 2014-11-26 诺华股份有限公司 为脑膜炎球菌因子h结合蛋白添加佐剂
WO2010109324A1 (en) 2009-03-24 2010-09-30 Novartis Ag Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
NZ598459A (en) 2009-08-27 2014-03-28 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
EP3017828A1 (en) 2009-08-27 2016-05-11 GlaxoSmithKline Biologicals SA Hybrid polypeptides including meningococcal fhbp sequences
CN102724988B (zh) 2009-09-30 2014-09-10 诺华股份有限公司 脑膜炎球菌fHBP多肽的表达
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
CN102869377A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
EP2545068B8 (en) 2010-03-11 2018-03-21 GlaxoSmithKline Biologicals S.A. Immunogenic composition or vaccine against gram-negative bacterial, for example neiserial, infection or disease
CA2793510A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
EP2585106A1 (en) 2010-06-25 2013-05-01 Novartis AG Combinations of meningococcal factor h binding proteins
AU2011284809B2 (en) * 2010-07-30 2015-04-02 Griffith University Recombinant Neisseria meningitidis Por A porin proteins.
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
US9259462B2 (en) 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
WO2012054879A1 (en) * 2010-10-22 2012-04-26 Duke University Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia
WO2012153302A1 (en) 2011-05-12 2012-11-15 Novartis Ag Antipyretics to enhance tolerability of vesicle-based vaccines
AU2011384634A1 (en) 2011-12-29 2014-06-19 Novartis Ag Adjuvanted combinations of meningococcal factor H binding proteins
BR112014019166A2 (pt) 2012-02-02 2017-07-04 Novartis Ag promotores para expressão aumentada de proteína em meningococos
EP2823312B1 (en) 2012-03-08 2019-08-07 GlaxoSmithKline Biologicals SA In vitro potency assay for protein-based meningococcal vaccines
NZ630133A (en) 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
JP6324961B2 (ja) 2012-09-06 2018-05-16 ノバルティス アーゲー 血清群ｂ髄膜炎菌とｄ／ｔ／ｐとの組み合わせワクチン
PL3110442T3 (pl) 2014-02-28 2021-04-19 Glaxosmithkline Biologicals Sa Zmodyfikowane meningokokowe polipeptydy fhbp
EP3799883A1 (en) 2016-11-25 2021-04-07 GlaxoSmithKline Biologicals S.A. Nomv-antigen conjugated compounds and use thereof
BE1025210B1 (fr) 2016-11-25 2018-12-12 Glaxosmithkline Biologicals Sa Conjugues immunogenes et leur utilisation
WO2024178355A1 (en) * 2023-02-24 2024-08-29 BioNTech SE Systems and methods for engineering synthetic antigens to promote tailored immune responses

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4550081A (en) 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0273116A3 (en) 1986-10-09 1990-05-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Gonococcal and meningococcal polypeptides, vaccines and diagnostics
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
US5144847A (en) 1988-03-24 1992-09-08 Johann Zach Pressure or force measuring device
JP3436756B2 (ja) * 1988-12-19 2003-08-18 アメリカン・サイアナミド・カンパニー 髄膜炎菌のクラスｉの外膜タンパク質のワクチン
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5646259A (en) 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
DE69612013T2 (de) 1995-11-21 2001-08-02 Yale University, New Haven Unimolekulare segmentamplifikation und bestimmung
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
WO1999024578A2 (en) 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
AU761780B2 (en) 1998-05-01 2003-06-12 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
WO2000061165A1 (en) * 1999-04-13 2000-10-19 Smithkline Beecham Corporation Conserved adhesin motif and methods of use thereof
EP1185691B1 (en) 1999-04-30 2009-04-29 Novartis Vaccines and Diagnostics, Inc. Neisseria genomic sequences and methods of their use
DK1228217T3 (da) 1999-04-30 2013-02-25 Novartis Vaccines & Diagnostic Konserverede neisseria-antigener
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
CZ304379B6 (cs) * 2000-01-25 2014-04-09 The University Of Queensland Proteiny obsahující konzervované oblasti povrchového antigenu NhhA z Neisseria meningitidis
EP1524993B1 (en) * 2002-08-02 2013-03-06 GlaxoSmithKline Biologicals s.a. Neisserial vaccine compositions comprising a combination of antigens
EP1706481A2 (en) * 2003-12-23 2006-10-04 GlaxoSmithKline Biologicals S.A. Vaccine

Also Published As

Publication number Publication date
WO2001055182A1 (en) 2001-08-02
CN102417537A (zh) 2012-04-18
AU2818101A (en) 2001-08-07
JP2003523208A (ja) 2003-08-05
US20090068216A1 (en) 2009-03-12
IL150822A (en) 2011-06-30
KR20020065938A (ko) 2002-08-14
NO20023487D0 (no) 2002-07-22
MXPA02007184A (es) 2004-02-26
NO332229B1 (no) 2012-08-06
EP1252182A1 (en) 2002-10-30
CN1419564A (zh) 2003-05-21
US7947291B2 (en) 2011-05-24
PL356819A1 (en) 2004-07-12
IL150822A0 (en) 2003-02-12
JP2012051902A (ja) 2012-03-15
US20020160016A1 (en) 2002-10-31
EP1252182B1 (en) 2012-06-20
CZ304379B6 (cs) 2014-04-09
US20090068229A1 (en) 2009-03-12
HUP0300696A2 (hu) 2003-07-28
JP2014024849A (ja) 2014-02-06
CA2398139A1 (en) 2001-08-02
ES2389719T3 (es) 2012-10-30
NZ520445A (en) 2004-02-27
EP2395013A3 (en) 2012-03-21
PL216780B1 (pl) 2014-05-30
KR100698561B1 (ko) 2007-03-21
EP2395013A2 (en) 2011-12-14
US8367070B2 (en) 2013-02-05
HUP0300696A3 (en) 2004-10-28
NO20023487L (no) 2002-09-24
US8383790B2 (en) 2013-02-26
EP1252182A4 (en) 2005-03-02
CZ20022482A3 (cs) 2003-01-15
US20130136762A1 (en) 2013-05-30
BR0107857A (pt) 2002-10-29

Similar Documents

Publication Publication Date Title
ZA200206153B (en) Proteins comprising conserved regions of Neisseria meningitidis surface antigent NhhA.
PT1228217E (pt) Antígenos de neisseria conservados
ITMI20002145A0 (it) Caffettiera
EP1434498A4 (en) SUBSTITUTE OF FATTY FORM OF HYDROLYZATE OF RICE FLOUR
TW567810U (en) Massage pillow
TW492296U (en) Multifunctional pillow for children
TW496157U (en) Massage chair
AU2002341634A1 (en) Peroral transduction of hepatocytes in the treatment of disease
HU2206U (en) Picture-frame
GB0104424D0 (en) Inflatible foot rocker
CA89698S (en) Walker
CA89697S (en) Walker
GB0029670D0 (en) Cutlery for invalids
UA5956S (uk) Кавоварка
HU0000369V0 (en) Pot for nemover of nail-polish
AU143140S (en) Statue
TW488231U (en) Chair for massaging
AUPR275901A0 (en) Improvements in design of pillows
GB0119365D0 (en) Foot rest
TW435705U (en) Glasses foot of eyeglasses
CA91160S (en) Carafe
CA95829S (en) Teapot
CA90858S (en) Teapot
CA90978S (en) Rocking chair
GB0005728D0 (en) Conserved antigens